Selected research
Industry Research
Artificial Intelligence Diagnostics Industry Research Report 2026
Market perspective
The global Artificial Intelligence Diagnostics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Artificial Intelligence Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Artificial Intelligence Diagnostics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Artificial Intelligence Diagnostics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Artificial Intelligence Diagnostics include Butterfly Network, Merative, Tempus, RetinAi, Nanox, Lunit, DiA Imaging, Subtle Medical and BrainMiner, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Artificial Intelligence Diagnostics market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Artificial Intelligence Diagnostics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artificial Intelligence Diagnostics Market by Company
Butterfly Network
Merative
Tempus
RetinAi
Nanox
Lunit
DiA Imaging
Subtle Medical
BrainMiner
GE
Siemens
Aidoc
Imagen Technologies, Inc.
VUNO, Inc.
Digital Diagnostics
NeuraSignal
Riverain Technologies, LLC
Philips
Microsoft
Viz.ai
RapidAI
Canon Medical
Enlitic
BioMind
ANNALISE-AI PTY LTD
icometrix
KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
Artificial Intelligence Diagnostics Segment by Type
Services
Software
Hardware
Artificial Intelligence Diagnostics Segment by Application
Radiology
Oncology
Neurology
Cardiology
Chest & Lungs
Others
Artificial Intelligence Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Artificial Intelligence Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Services
- Software
- Hardware
Applications
- Radiology
- Oncology
- Neurology
- Cardiology
- Chest & Lungs
- Others
Companies covered
- Butterfly Network
- Merative
- Tempus
- RetinAi
- Nanox
- Lunit
- DiA Imaging
- Subtle Medical
- BrainMiner
- GE
- Siemens
- Aidoc
- Imagen Technologies, Inc.
- VUNO, Inc.
- Digital Diagnostics
- NeuraSignal
- Riverain Technologies, LLC
- Philips
- Microsoft
- Viz.ai
- RapidAI
- Canon Medical
- Enlitic
- BioMind
- ANNALISE-AI PTY LTD
- icometrix
- KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Artificial Intelligence Diagnostics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Services
- 2.2.3 Software
- 2.2.4 Hardware
- 2.3 Artificial Intelligence Diagnostics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Radiology
- 2.3.3 Oncology
- 2.3.4 Neurology
- 2.3.5 Cardiology
- 2.3.6 Chest & Lungs
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Artificial Intelligence Diagnostics Breakdown Data by Type
- 3.1 Global Artificial Intelligence Diagnostics Historic Market Size by Type (2021-2026)
- 3.2 Global Artificial Intelligence Diagnostics Forecasted Market Size by Type (2027-2032)
4 Artificial Intelligence Diagnostics Breakdown Data by Application
- 4.1 Global Artificial Intelligence Diagnostics Historic Market Size by Application (2021-2026)
- 4.2 Global Artificial Intelligence Diagnostics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Artificial Intelligence Diagnostics Market Perspective (2021-2032)
- 5.2 Global Artificial Intelligence Diagnostics Growth Trends by Region
- 5.2.1 Global Artificial Intelligence Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Artificial Intelligence Diagnostics Historic Market Size by Region (2021-2026)
- 5.2.3 Artificial Intelligence Diagnostics Forecasted Market Size by Region (2027-2032)
- 5.3 Artificial Intelligence Diagnostics Market Dynamics
- 5.3.1 Artificial Intelligence Diagnostics Industry Trends
- 5.3.2 Artificial Intelligence Diagnostics Market Drivers
- 5.3.3 Artificial Intelligence Diagnostics Market Challenges
- 5.3.4 Artificial Intelligence Diagnostics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Artificial Intelligence Diagnostics Players by Revenue
- 6.1.1 Global Top Artificial Intelligence Diagnostics Players by Revenue (2021-2026)
- 6.1.2 Global Artificial Intelligence Diagnostics Revenue Market Share by Players (2021-2026)
- 6.2 Global Artificial Intelligence Diagnostics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Artificial Intelligence Diagnostics Head Office and Area Served
- 6.4 Global Artificial Intelligence Diagnostics Players, Product Type & Application
- 6.5 Global Artificial Intelligence Diagnostics Manufacturers Established Date
- 6.6 Global Artificial Intelligence Diagnostics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Artificial Intelligence Diagnostics Market Size (2021-2032)
- 7.2 North America Artificial Intelligence Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Artificial Intelligence Diagnostics Market Size by Country (2021-2026)
- 7.4 North America Artificial Intelligence Diagnostics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Artificial Intelligence Diagnostics Market Size (2021-2032)
- 8.2 Europe Artificial Intelligence Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Artificial Intelligence Diagnostics Market Size by Country (2021-2026)
- 8.4 Europe Artificial Intelligence Diagnostics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Artificial Intelligence Diagnostics Market Size (2021-2032)
- 9.2 Asia-Pacific Artificial Intelligence Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Artificial Intelligence Diagnostics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Artificial Intelligence Diagnostics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Artificial Intelligence Diagnostics Market Size (2021-2032)
- 10.2 South America Artificial Intelligence Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Artificial Intelligence Diagnostics Market Size by Country (2021-2026)
- 10.4 South America Artificial Intelligence Diagnostics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Artificial Intelligence Diagnostics Market Size (2021-2032)
- 11.2 Middle East & Africa Artificial Intelligence Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Artificial Intelligence Diagnostics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Artificial Intelligence Diagnostics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Butterfly Network
- 12.1.1 Butterfly Network Company Information
- 12.1.2 Butterfly Network Business Overview
- 12.1.3 Butterfly Network Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.1.4 Butterfly Network Artificial Intelligence Diagnostics Product Portfolio
- 12.1.5 Butterfly Network Recent Developments
- 12.2 Merative
- 12.2.1 Merative Company Information
- 12.2.2 Merative Business Overview
- 12.2.3 Merative Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.2.4 Merative Artificial Intelligence Diagnostics Product Portfolio
- 12.2.5 Merative Recent Developments
- 12.3 Tempus
- 12.3.1 Tempus Company Information
- 12.3.2 Tempus Business Overview
- 12.3.3 Tempus Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.3.4 Tempus Artificial Intelligence Diagnostics Product Portfolio
- 12.3.5 Tempus Recent Developments
- 12.4 RetinAi
- 12.4.1 RetinAi Company Information
- 12.4.2 RetinAi Business Overview
- 12.4.3 RetinAi Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.4.4 RetinAi Artificial Intelligence Diagnostics Product Portfolio
- 12.4.5 RetinAi Recent Developments
- 12.5 Nanox
- 12.5.1 Nanox Company Information
- 12.5.2 Nanox Business Overview
- 12.5.3 Nanox Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.5.4 Nanox Artificial Intelligence Diagnostics Product Portfolio
- 12.5.5 Nanox Recent Developments
- 12.6 Lunit
- 12.6.1 Lunit Company Information
- 12.6.2 Lunit Business Overview
- 12.6.3 Lunit Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.6.4 Lunit Artificial Intelligence Diagnostics Product Portfolio
- 12.6.5 Lunit Recent Developments
- 12.7 DiA Imaging
- 12.7.1 DiA Imaging Company Information
- 12.7.2 DiA Imaging Business Overview
- 12.7.3 DiA Imaging Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.7.4 DiA Imaging Artificial Intelligence Diagnostics Product Portfolio
- 12.7.5 DiA Imaging Recent Developments
- 12.8 Subtle Medical
- 12.8.1 Subtle Medical Company Information
- 12.8.2 Subtle Medical Business Overview
- 12.8.3 Subtle Medical Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.8.4 Subtle Medical Artificial Intelligence Diagnostics Product Portfolio
- 12.8.5 Subtle Medical Recent Developments
- 12.9 BrainMiner
- 12.9.1 BrainMiner Company Information
- 12.9.2 BrainMiner Business Overview
- 12.9.3 BrainMiner Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.9.4 BrainMiner Artificial Intelligence Diagnostics Product Portfolio
- 12.9.5 BrainMiner Recent Developments
- 12.10 GE
- 12.10.1 GE Company Information
- 12.10.2 GE Business Overview
- 12.10.3 GE Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.10.4 GE Artificial Intelligence Diagnostics Product Portfolio
- 12.10.5 GE Recent Developments
- 12.11 Siemens
- 12.11.1 Siemens Company Information
- 12.11.2 Siemens Business Overview
- 12.11.3 Siemens Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.11.4 Siemens Artificial Intelligence Diagnostics Product Portfolio
- 12.11.5 Siemens Recent Developments
- 12.12 Aidoc
- 12.12.1 Aidoc Company Information
- 12.12.2 Aidoc Business Overview
- 12.12.3 Aidoc Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.12.4 Aidoc Artificial Intelligence Diagnostics Product Portfolio
- 12.12.5 Aidoc Recent Developments
- 12.13 Imagen Technologies, Inc.
- 12.13.1 Imagen Technologies, Inc. Company Information
- 12.13.2 Imagen Technologies, Inc. Business Overview
- 12.13.3 Imagen Technologies, Inc. Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.13.4 Imagen Technologies, Inc. Artificial Intelligence Diagnostics Product Portfolio
- 12.13.5 Imagen Technologies, Inc. Recent Developments
- 12.14 VUNO, Inc.
- 12.14.1 VUNO, Inc. Company Information
- 12.14.2 VUNO, Inc. Business Overview
- 12.14.3 VUNO, Inc. Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.14.4 VUNO, Inc. Artificial Intelligence Diagnostics Product Portfolio
- 12.14.5 VUNO, Inc. Recent Developments
- 12.15 Digital Diagnostics
- 12.15.1 Digital Diagnostics Company Information
- 12.15.2 Digital Diagnostics Business Overview
- 12.15.3 Digital Diagnostics Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.15.4 Digital Diagnostics Artificial Intelligence Diagnostics Product Portfolio
- 12.15.5 Digital Diagnostics Recent Developments
- 12.16 NeuraSignal
- 12.16.1 NeuraSignal Company Information
- 12.16.2 NeuraSignal Business Overview
- 12.16.3 NeuraSignal Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.16.4 NeuraSignal Artificial Intelligence Diagnostics Product Portfolio
- 12.16.5 NeuraSignal Recent Developments
- 12.17 Riverain Technologies, LLC
- 12.17.1 Riverain Technologies, LLC Company Information
- 12.17.2 Riverain Technologies, LLC Business Overview
- 12.17.3 Riverain Technologies, LLC Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.17.4 Riverain Technologies, LLC Artificial Intelligence Diagnostics Product Portfolio
- 12.17.5 Riverain Technologies, LLC Recent Developments
- 12.18 Philips
- 12.18.1 Philips Company Information
- 12.18.2 Philips Business Overview
- 12.18.3 Philips Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.18.4 Philips Artificial Intelligence Diagnostics Product Portfolio
- 12.18.5 Philips Recent Developments
- 12.19 Microsoft
- 12.19.1 Microsoft Company Information
- 12.19.2 Microsoft Business Overview
- 12.19.3 Microsoft Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.19.4 Microsoft Artificial Intelligence Diagnostics Product Portfolio
- 12.19.5 Microsoft Recent Developments
- 12.20 Viz.ai
- 12.20.1 Viz.ai Company Information
- 12.20.2 Viz.ai Business Overview
- 12.20.3 Viz.ai Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.20.4 Viz.ai Artificial Intelligence Diagnostics Product Portfolio
- 12.20.5 Viz.ai Recent Developments
- 12.21 RapidAI
- 12.21.1 RapidAI Company Information
- 12.21.2 RapidAI Business Overview
- 12.21.3 RapidAI Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.21.4 RapidAI Artificial Intelligence Diagnostics Product Portfolio
- 12.21.5 RapidAI Recent Developments
- 12.22 Canon Medical
- 12.22.1 Canon Medical Company Information
- 12.22.2 Canon Medical Business Overview
- 12.22.3 Canon Medical Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.22.4 Canon Medical Artificial Intelligence Diagnostics Product Portfolio
- 12.22.5 Canon Medical Recent Developments
- 12.23 Enlitic
- 12.23.1 Enlitic Company Information
- 12.23.2 Enlitic Business Overview
- 12.23.3 Enlitic Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.23.4 Enlitic Artificial Intelligence Diagnostics Product Portfolio
- 12.23.5 Enlitic Recent Developments
- 12.24 BioMind
- 12.24.1 BioMind Company Information
- 12.24.2 BioMind Business Overview
- 12.24.3 BioMind Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.24.4 BioMind Artificial Intelligence Diagnostics Product Portfolio
- 12.24.5 BioMind Recent Developments
- 12.25 ANNALISE-AI PTY LTD
- 12.25.1 ANNALISE-AI PTY LTD Company Information
- 12.25.2 ANNALISE-AI PTY LTD Business Overview
- 12.25.3 ANNALISE-AI PTY LTD Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.25.4 ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Product Portfolio
- 12.25.5 ANNALISE-AI PTY LTD Recent Developments
- 12.26 icometrix
- 12.26.1 icometrix Company Information
- 12.26.2 icometrix Business Overview
- 12.26.3 icometrix Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.26.4 icometrix Artificial Intelligence Diagnostics Product Portfolio
- 12.26.5 icometrix Recent Developments
- 12.27 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
- 12.27.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Company Information
- 12.27.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Business Overview
- 12.27.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Revenue in Artificial Intelligence Diagnostics Business (2021-2026)
- 12.27.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Artificial Intelligence Diagnostics Product Portfolio
- 12.27.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst